Effect of high-salt diet or chronic captopril treatment on exercise capacity in normotensive rats

Clinical and Experimental Pharmacology and Physiology

Volumn 31, Issue 4, 2004, Pages 197-201

  Minami, Naoyoshi ^a   Mori, Nobuyoshi ^a   Nagasaka, Makoto ^a   Harada, Taku ^a   Kurosawa, Hajime ^a   Kanazawa, Masayuki ^a   Kohzuki, Masahiro ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin converting enzyme inhibition; Dietary sodium chloride; Lactate; Rats

Indexed keywords

CAPTOPRIL; LACTIC ACID;

ARTERY CATHETER; ARTICLE; BLOOD PRESSURE; CAROTID ARTERY; CONTROLLED STUDY; DIET; EXERCISE; HIGH SODIUM INTAKE; LACTATE BLOOD LEVEL; MALE; MICROVASCULARIZATION; NONHUMAN; RAT; REDUCTION; SKELETAL MUSCLE; TREADMILL; VELOCITY;

ANIMALS; BLOOD PRESSURE; CAPTOPRIL; EXERCISE TEST; HEART RATE; MALE; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHLORIDE, DIETARY;

EID: 1942537847     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2004.03980.x     Document Type: Article

References (37)

1. Wang DH, Prewitt RL. Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats. Hypertension 1990; 15: 68-77.
2. Wang DH, Prewitt RL. Longitudinal effect of captopril on aortic and arteriolar development in normotensive rats. Am. J. Physiol. 1991; 260: H1959-65.
3. Hernandez I, Cowley Jr AW, Lombard JH, Greene AS. Salt intake and angiotensin II alter microvessel density in the cremaster muscle of normal rats. Am. J. Physiol. 1992; 263: H664-7.
4. Frisbee JC, Weber DS, Lombard JH. Chronic captopril administration decreases vasodilator responses in skeletal muscle arteriole. Am. J. Hypertens. 1999; 12: 705-15.
5. Weber DS, Lombard JH. Elevated salt intake impairs dilation of skeletal muscle resistance arteries via angiotensin II suppression. Am. J. Physiol. 2000; 278: H500-6.
6. O'Drobinak DM, Greene AS. Decreases in steady-state muscle performance and vessel density in reduced renal mass hypertensive rats. Am. J. Physiol. 1996; 270: H661-7.
7. Kohzuki M, Kamimoto M, Wu X-M et al. Renal protective effects of chronic exercise and antihypertensive therapy in hypertensive rats with chronic renal failure. J. Hypertens. 2001; 19: 1877-82.
8. Shimojo N, Naka K, Uenoyama H, Hamamoto K, Yoshioka K, Okuda K. Electrochemical assay system with single-use electrode strip for measuring lactate in whole blood. Clin. Chem. 1993; 39: 2312-14.
9. Medbø JI, Mamen A, Hoh Olsen O, Evertsen F. Examination of four different instruments for measuring blood lactate concentration. Scand. J. Clin. Lab. Invest. 2000; 60: 367-80.
10. Wagner PD. Determinants of maximal oxygen transport and utilization. Annu. Rev. Physiol. 1996; 58: 21-50.
11. 2 in dog gastrocnemius muscle in situ. J. Appl. Physiol. 1993; 74: 1697-703.
12. Halliwill JR. Mechanisms and clinical implications of post-exercise hypotension in humans. Exerc. Sports Sci. Rev. 2001; 29: 65-70.
13. Fagard R, Lijnen P, Vanhees L, Amery A. Hemodynamic response to converting enzyme inhibition at rest and exercise in humans. J. Appl. Physiol. 1982; 53: 576-81.
14. Hohimer AR, Hales JR, Rowell LB, Smith OA. Regional distribution of blood flow during mild dynamic exercise in the baboon. J. Appl. Physiol. 1983; 55: 1173-7.
15. Greene AS, Tonellato PJ, Lui J, Lombard JH, Cowley Jr AW. Microvascular rarefaction and tissue vascular resistance in hypertension. Am. J. Physiol. 1989; 256: H126-31.
16. Missaut L, Duprez D, de Buyzere M, de Backer G, Clement D. Decreased exercise capacity in mild essential hypertension: Non-invasive indicators of limiting factors. J. Hum. Hypertens. 1992; 6: 151-5.
17. Sullivan JM, Prewitt RL, Josephs JA. Attenuation of the microcirculation in young patients with high-output borderline hypertension. Hypertension 1983; 5: 844-51.
18. Guazzi M, Brenner DA, Apstein CS, Saupe KW. Exercise intolerance in rats with hypertensive heart disease is associated with impaired diastolic relaxation. Hypertension 2001; 37: 204-8.
19. Van Baak MA, Mooij JMV, Wijnen JAG, Tan FS. Submaximal endurance exercise performance during enalapril treatment in patients with essential hypertension. Clin. Pharmacol. Ther. 1991; 50: 221-7.
20. Linz W, Wiemer G, Gohlke P, Unger T, Schölkens BA. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol. Rev. 1995; 47: 25-49.
21. Dietze G, Wicklmayr M. Evidence for a participation of the kallikreinkinin system in the regulation of muscle metabolism during muscular work. FEBS Lett. 1977; 74: 205-8.
22. Shiuchi T, Cui T-X, Wu L et al. ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO. Hypertension 2002; 40: 329-34.
23. Rett K, Jauch KW, Wicklemayr M, Dietze G, Fink E, Mehnert H. Angiotensin converting enzyme inhibitors in diabetes. Experimental and human evidence. Postgrad. Med. J. 1986; 62 (Suppl. 1): 59-64.
24. Stanley WC, Gertz EW, Wisnski JA, Morris DL, Neese RA, Brooks GA. Systemic lactate kinetics during graded exercise in man. Am. J. Physiol. 1985; 249: E595-602.
25. Gladden LB. Net lactate uptake during progressive steady-level contractions in canine skeletal muscle. J. Appl. Physiol. 1991; 71: 514-20.
26. Juel C, Bangsbo J, Graham T, Saltin B. Lactate and potassium fluxes from human skeletal muscle during and after intense, dynamic, knee extensor exercise. Acta Physiol. Scand. 1990; 140: 147-59.
27. Katz A, Sahlin K. Regulation of lactic acid production during exercise. J. Appl. Physiol. 1988; 65: 509-18.
28. Davis JA, Vodak P, Wilmore JH, Vodak J, Kurts P. Anaerobic threshold and maximal aerobic power for three modes of exercise. J. Appl. Physiol. 1976; 4: 544-50.
29. Farrel PA, Wilmore JH, Coyle EF, Billing JE, Costill DL. Plasma lactate accumulation and distance running performance. Med. Sci. Sports 1979; 11: 338-44.
30. Shen W, Hintze TH, Wolin MS. Nitric oxide. An important signalling mechanism between vascular endothelium and parenchymal cells in the regulation of oxygen consumption. Circulation 1995; 92: 1086-95.
31. Stainby WN, Brooks GA. Control of lactic acid metabolism in contracting muscles during exercise. Exerc. Sports Sci. Rev. 1990; 18: 29-63.
32. Brooks GA. Anaerobic threshold: A review of the concept and directions for future research. Med. Sci. Sports Exerc. 1985; 17: 22-31.
33. Scrogin KE, Hatton DC, McCarron DA. The interactive effects of dietary sodium chloride and calcium on cardiovascular stress responses. Am. J. Physiol. 1991; 261: R945-9.
34. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 1990; 86: 1343-6.
35. Jan Danser AH, Schalekamp MADH, Bax WA et al. Angiotensin-converting enzyme in the human heart: Effect of the deletion/insertion polymorphism. Circulation 1995; 92: 1387-8.
36. Abraham MR, Olson LJ, Joyner MJ, Turner ST, Beck KC, Johnson BD. Angiotensin-converting enzyme genotype modulates pulmonary function and exercise capacity in treated patients with congestive stable heart failure. Circulation 2002; 106: 1794-9.
37. Williams AG, Rayson MP, Jubb M et al. The ACE gene and muscle performance. Nature 2000; 403: 614.